Clinical Trial: Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Study Status: Terminated
Recruit Status: Terminated
Study Type: Interventional




Official Title: Topiramate as an Adjunct to Amantadine in the Treatment of Dyskinesia in Parkinson's Disease

Brief Summary: The study will involve an eighteen-week, double-blind, placebo-controlled parallel designed comparison between add-on topiramate and add-on placebo to stable treatment with amatadine in the treatment of PD patients who continue to have dyskinesia on amantadine.